Melatonin for memory loss in Alzheimer's disease
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether taking melatonin for 3 months can slow down memory loss and protect the brain in people with early Alzheimer's disease. Melatonin is a natural hormone that helps regulate sleep, and it may also have protective effects on the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 60 and 90 years old.
- You must have memory or thinking problems that you have talked to a doctor about.
- You need to be able to have brain scans like MRI and PET scans.
- You should be able to do memory tests and physical tests at the hospital.
- If you take memory medications, you must have been on the same dose for at least 3 months (or 1 month for other meds).
- You cannot be taking sleeping pills in the 2 weeks before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking 5 mg of melatonin can improve thinking and brain health over time in older adults with early, mild symptoms. You may help researchers learn which brain changes and measures improve with melatonin.
This study tests whether a daily pill (tadalafil, a type of medicine usually used for blood pressure or erectile dysfunction) can help people with early Alzheimer's or mild memory problems. It aims to see if this drug can improve memory and slow down the disease, with the help of regular checkups and brain scans.
This study tests whether regular “gamma” light and sound stimulation can delay or prevent Alzheimer’s disease-related memory decline in people who are currently not showing dementia but are at higher risk. It uses brain testing (MRI and PET) and memory/language tests over about 13 months.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This trial tests whether changing caffeine intake can improve thinking and brain function in people with Alzheimer’s disease. You may qualify if you can follow a low-caffeine diet and have stable Alzheimer’s treatment and sleep/heart conditions.
This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.
Hear when a new Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.